Kezar Life Sciences Inc (KZR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $6.70
• Market Cap: $49.50M
• EPS: $-8.44
• 52-Week High: $6.86
• 52-Week Low: $3.53

About Kezar Life Sciences Inc

Kezar Life Sciences, Inc. is a promising clinical-stage biotechnology company headquartered in South San Francisco, California, focused on the development of innovative small molecule therapies targeting immune-mediated diseases and cancer. Leveraging its proprietary drug discovery platform, Kezar is committed to addressing significant unmet medical needs with a strong and diverse pipeline of candidates in various stages of clinical development. This strategic focus not only positions the com...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Kezar Life Sciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does KZR pay dividends?

Kezar Life Sciences Inc (KZR) does not currently pay a regular dividend.

What is KZR's market cap?

Kezar Life Sciences Inc (KZR) has a market capitalization of $49.50M with a current stock price of $6.70.